{"mainPropery":{"diseaseId":6619,"diseaseName":"Hereditary coproporphyria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6619/hereditary-coproporphyria","synonyms":["Coproporphyria","Coproporphyria hereditary","Hereditary coproporphyria porphyria","Porphyria hepatica coproporphyria","Porphyria hepatica II","HCP","Coproporphyrinogen oxidase deficiency","CPO deficiency","CPRO deficiency","CPX deficiency"],"synonyms-with-source":[{"name":"Coproporphyria"},{"name":"Coproporphyria hereditary"},{"name":"Hereditary coproporphyria porphyria"},{"name":"Porphyria hepatica coproporphyria"},{"name":"Porphyria hepatica II"},{"name":"HCP"},{"name":"Coproporphyrinogen oxidase deficiency"},{"name":"CPO deficiency"},{"name":"CPRO deficiency"},{"name":"CPX deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"121300"},{"identifierType":"ORPHANET","identifierId":"79273"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":69,"resourceName":" American Porphyria Foundation","abbreviation":"","address1":"4915 St. Elmo Avenue","address2":"Suite 105","address3":"","address4":"","address5":"","city":"Bethesda","state":"MD","zip":"20814","country":"United States","phone":"+1-301-347-7166","tty":"","tollFree":"1-866-273-3635","fax":"+1-301-312-8719","email":"porphyrus@porphyriafoundation.com","url":"https://porphyriafoundation.org/","freeText":""},{"resourceID":942,"resourceName":"American Association for the Study of Liver Diseases","abbreviation":"","address1":"1001 North Fairfax, 4th floor","address2":"","address3":"","address4":"","address5":"","city":"Alexandria","state":"VA","zip":"22314","country":"United States","phone":"703–299–9766","tty":"","tollFree":"","fax":"703–299–9622","email":"aasld@aasld.org","url":"http://www.aasld.org/","freeText":""},{"resourceID":943,"resourceName":"American Liver Foundation","abbreviation":"","address1":"39 Broadway, Suite 2700","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10006","country":"United States","phone":"+1-212-668-1000","tty":"","tollFree":"+1-800-465-4837 (Helpline)","fax":"","email":"https://liverfoundation.org/for-patients/contact-us/","url":"https://liverfoundation.org/","freeText":""},{"resourceID":3192,"resourceName":"European Porphyria Network","abbreviation":"EPNET","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"https://porphyria.eu/en/contact","url":"https://porphyria.eu/en","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/121300' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=Hereditary+coproporphyria+%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Hereditary coproporphyria. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=porphyria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Hereditary coproporphyria. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/porphyria' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":876,"resourceId":1582,"resourceName":"RDCRN - Porphyrias Consortium","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/cms/porphyrias/' target='_blank'>Porphyrias Consortium</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition&nbsp;through research. The&nbsp;Porphyrias Consortium has a registry for patients who wish to be contacted about clinical research opportunities. <br />\r\n<br />\r\nFor more information on the registry see:&nbsp;<a href='https://www.rarediseasesnetwork.org/cms/porphyrias/registry' target='_blank'>https://www.rarediseasesnetwork.org/cms/porphyrias/registry</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1366,"resourceId":2017,"resourceName":"Porphyria Disease Management","descriptionText":"The American Porphyria Foundation offers a <a href='https://www.porphyriafoundation.org/for-patients/about-porphyria/' target='_blank'>document</a> that includes information about porphyria, types, testing, and treatment with <a href='https://porphyriafoundation.org/patients/about-porphyria/treatment-options' target='_blank'>Panhematin</a><sup>&#174;</sup>.  Click the \"document\" link above to view these guidelines.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0162531' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/323/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001208.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/205374-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79273' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK114807/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1549,"resourceId":2177,"resourceName":"National Human Genome Research Institute","descriptionText":"The <a href='http://www.genome.gov/19016728' target='_blank'>National Human Genome Research Institute's</a> (NHGRI) website has an information page on this topic. NHGRI is part of the National Institutes of Health and supports research on the structure and function of the human genome and its role in health and disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1557,"resourceId":2183,"resourceName":"National Digestive Diseases Information Clearinghouse","descriptionText":"The <a href='https://www.niddk.nih.gov/health-information/liver-disease/porphyria' target='_blank'>National Digestive Diseases Information Clearinghouse</a> (NIDDK) offers information on this condition.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_AcuteHepaticPorphyria.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2036,"resourceId":69,"resourceName":" American Porphyria Foundation","descriptionText":"The <a href='https://www.porphyriafoundation.org/for-patients/types-of-porphyria/hcp/' target='_blank'>The American Porphyria Foundation</a> offers an information page on Hereditary coproporphyria. Please click on the link to access this resource.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:121300' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2161,"resourceId":3369,"resourceName":"HealthWell Foundation","descriptionText":"The <a href='http://www.healthwellfoundation.org/porphyrias' target='_blank'>HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":2065,"questionText":"What is hereditary coproporphyria?","answerText":"<strong>Hereditary coproporphyria&nbsp;</strong>(HCP)<strong> </strong>is a rare inherited form of liver (hepatic) <a href=\"http://rarediseases.info.nih.gov/GARD/Disease.aspx?diseaseID=10353\" target=\"_blank\">porphyria</a>, characterized by neurological symptoms in the form of episodes (acute attacks) of stomach&nbsp;pain, nausea, vomiting, weakness, numbness, and pain in the hands and feet (<a href=\"https://medlineplus.gov/peripheralnervedisorders.html\" target=\"_blank\">neuropathy</a>).[1265][12347] The porphyrias are a group of blood conditions caused by a lack of an enzyme in the body that makes heme, an important molecule that carries oxygen throughout the body and is vital for all of the body&rsquo;s organs.[1265] Symptoms usually begin around 20-30 years of age, but have been reported at younger ages. Signs and symptoms present during the attacks may include body pain, nausea and vomiting, increased heart rate (<a href=\"https://www.mayoclinic.org/diseases-conditions/tachycardia/symptoms-causes/syc-20355127?p=1\" target=\"_blank\">tachycardia</a>), and high blood pressure.[12347]&nbsp; Less common symptoms include seizures, skin lesions, and paralysis of the arms and legs, body trunk, and respiratory muscles. Most individuals with HCP do not have any signs or symptoms between attacks.[15353] HCP is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"https://ghr.nlm.nih.gov/gene/CPOX#\" target=\"_blank\">CPOX</a>&nbsp;</em>gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner.[1268] Diagnosis is based on the symptoms and specific blood, urine and stool testing. Treatment is based on preventing the symptoms. An acute attack requires hospitalization, medications, and treatment with <g class=\"gr_ gr_3423 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del\" id=\"3423\" data-gr-id=\"3423\">heme</g> therapy.[15354]&nbsp;&nbsp;<br />\r\n<br />","dateModified":"2019-09-04T00:00:00"},"basicQuestions":[{"questionId":2066,"questionText":"What are the signs and symptoms of hereditary&nbsp;coproporphyria (HCP)?","answerText":"The symptoms of hereditary coproporphyria (HCP) may be different from person to person. Some people may be more severely affected than others and not everyone with hereditary coproporphyria will have the same symptoms. Many individuals with a<em> <a href=\"https://ghr.nlm.nih.gov/gene/CPOX#\" target=\"_blank\">CPOX</a></em> gene <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> do not experience any symptoms of HCP.[15353][15355]&nbsp;<br />\r\n<br />\r\nIn&nbsp;people with HCP,&nbsp;additional factors; such as hormonal changes, certain drugs, excess alcohol consumption, infections, and fasting or dietary changes; may trigger the appearance of symptoms. Symptoms appear as acute attacks or episodes that develop over a period of days. The timing and severity of attacks vary from one person to another.[1265]<br />\r\n<br />\r\nThe symptoms of an acute attack include:[12347]<br />\r\n<br />\r\n&bull;<span style=\"white-space: pre;\">\t</span>Severe stomach pain leading to nausea and vomiting<br />\r\n<span style=\"white-space: pre;\">\t\t</span>-back and leg pain<br />\r\n&bull;<span style=\"white-space: pre;\">\t</span>High blood pressure<br />\r\n&bull;<span style=\"white-space: pre;\">\t</span>Rapid heartbeat (<a href=\"https://www.mayoclinic.org/diseases-conditions/tachycardia/symptoms-causes/syc-20355127?p=1\" target=\"_blank\">tachycardia</a>)<br />\r\n&bull;<span style=\"white-space: pre;\">\t</span>Seizures (less common)<br />\r\n&bull;<span style=\"white-space: pre;\">\t</span>Weakness, numbness in the arms and legs (<a href=\"https://medlineplus.gov/peripheralnervedisorders.html\" target=\"_blank\">peripheral neuropathy</a>)<br />\r\n&bull;<span style=\"white-space: pre;\">\t</span>Skin findings (in about 20% of people with HCP)<br />\r\n<span style=\"white-space: pre;\">\t\t</span>-extreme sensitivity to sunlight (photosensitivity)<br />\r\n<span style=\"white-space: pre;\">\t\t</span>-fragile skin<br />\r\n<br />\r\nIn between attacks, people with HCP are often symptom-free.&nbsp;<br />\r\n<br />\r\n&nbsp;<br />","dateModified":"2019-04-09T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1265,"authors":"Tishler, Peter","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"Updated 2014","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/hereditary-coproporphyria/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12347,"authors":"Wang B, Bissell, DM","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Nov. 8, 2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK114807/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15353,"authors":"Wang B, Rudnick S, Cengia B, Bonkovsky HL","articleTitle":"Acute hepatic porphyrias: Review and recent progress","bookWebsiteJournalTitle":"Hepato Comm","date":"Dec 20, 2018","volume":"3(2)","pages":"193-206","url":"https://www.ncbi.nlm.nih.gov/pubmed/30766957","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15355,"authors":"Stein PE, Badminton MN, Rees DC.","articleTitle":"Update review of the acute porphyrias","bookWebsiteJournalTitle":"Br Jl Hemot","date":"2017","volume":"176(4)","pages":"527-538","url":"https://www.ncbi.nlm.nih.gov/pubmed/27982422","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2068,"questionText":"What causes hereditary coproporphyria?","answerText":"Hereditary coproporphyria (HCP) is caused by a genetic change (mutation in the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/CPOX\" target=\"_blank\">CPOX</a>&nbsp;</em>gene.&nbsp; However, having a <em>CPOX </em>gene mutation alone does not cause symptoms. Additional factors (such as hormonal changes, specific drugs, excess alcohol, fasting) are needed to trigger an attack and the appearance of symptoms.&nbsp; Some people with <em>CPOX</em> gene mutations never have symptoms of HCP.[12347]<br />\r\n<br />\r\nThe American Porphyria Foundation offers a <a href=\"https://porphyriafoundation.org/healthcare-professionals/drug-safety\" target=\"_blank\">drug&nbsp;database</a> with safety information about the interaction of specific drugs in patients with porphyria.&nbsp;<br />\r\n<br />","dateModified":"2019-04-09T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":12347,"authors":"Wang B, Bissell, DM","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Nov. 8, 2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK114807/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13285,"questionText":"How is hereditary coproporphyria inherited?","answerText":"Hereditary coproporphyria (HCP) is inherited in an autosomal dominant pattern.[1265][12347] All individuals inherit two copies of each gene. In autosomal dominant conditions, having a mutation in just one copy of the <em><a href=\"https://ghr.nlm.nih.gov/gene/CPOX\" target=\"_blank\">CPOX</a></em>&nbsp;gene causes the person to have HCP. The mutation can be inherited from either parent. Some people are born with hereditary coproporphyria due to a new genetic mutation (de novo) and do not have a history of this condition in their family. There is nothing either parent can do, before or during&nbsp;pregnancy, to cause a child to have this.<br />\r\n<br />\r\nEach child of an individual with an autosomal dominant condition has a 50% or 1 in 2 chance of inheriting the mutation and the condition. Offspring who inherit the mutation may develop HCP, although they could be more or less severely affected than their parent. Sometimes a person may have a <em>CPOX</em> gene mutation for HCP and show no signs or symptoms of it.&nbsp;&nbsp;<br />\r\n<br />","dateModified":"2019-04-09T13:04:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1265,"authors":"Tishler, Peter","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"Updated 2014","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/hereditary-coproporphyria/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12347,"authors":"Wang B, Bissell, DM","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Nov. 8, 2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK114807/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2067,"questionText":"How is hereditary coproporphyria diagnosed?","answerText":"The diagnosis of hereditary coproporphyria (HCP) is suspected first based on the clinical signs and symptoms, usually during an acute attack.&nbsp; Once a person is suspected of having HCP, examination of urine, blood, and stool (fecal) samples is typically done.&nbsp; These lab tests are usually done at the time of the acute attack and look for elevated levels of compounds found to be associated with several different types of porphyria.[12347][15355]<br />\r\n<br />\r\nTo identify the specific type of porphyria an individual has, genetic testing can be performed to look for mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/CPOX\" target=\"_blank\">CPOX</a></em> gene.[12347]&nbsp; &nbsp;&nbsp;<br />\r\n<br />\r\nAt least one study suggesting diagnostic criteria for the acute dominantly inherited forms of porphyria has been published.[15356]","dateModified":"2019-04-09T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":1265,"authors":"Tishler, Peter","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"Updated 2014","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/hereditary-coproporphyria/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12347,"authors":"Wang B, Bissell, DM","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Nov. 8, 2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK114807/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15355,"authors":"Stein PE, Badminton MN, Rees DC.","articleTitle":"Update review of the acute porphyrias","bookWebsiteJournalTitle":"Br Jl Hemot","date":"2017","volume":"176(4)","pages":"527-538","url":"https://www.ncbi.nlm.nih.gov/pubmed/27982422","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15356,"authors":"Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN","articleTitle":"Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene","bookWebsiteJournalTitle":"Clin Chem","date":"2009","volume":"55","pages":"1406-1414","url":"https://www.ncbi.nlm.nih.gov/pubmed/19460837","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13286,"questionText":"How might hereditary coproporphyria be treated?&nbsp;","answerText":"There is no specific treatment for hereditary coproporphyria (HCP). Treatment is aimed at managing the symptoms of HCP that occur during an acute attack. Hospitalization is often necessary for acute attacks, and medications for pain, nausea <g class=\"gr_ gr_23 gr-alert gr_gramm gr_inline_cards gr_run_anim Punctuation only-ins replaceWithoutSep\" id=\"23\" data-gr-id=\"23\">and</g> vomiting, and close observation are generally required. Some attacks may be managed by giving the person a large amount of glucose or other carbohydrates. More severe attacks are treated with <g class=\"gr_ gr_18 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del\" id=\"18\" data-gr-id=\"18\">heme</g> therapy, given through a vein (intravenously).&nbsp;<a href=\"https://porphyriafoundation.org/patients/about-porphyria/treatment-options\" target=\"_blank\">Panhematin&reg;</a> is currently the only commercially available heme therapy for treatment and prevention of acute porphyria attacks in the United States. Heme <g class=\"gr_ gr_21 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling\" id=\"21\" data-gr-id=\"21\">arginate</g>, which is marketed in some other countries, is another type of <g class=\"gr_ gr_20 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del\" id=\"20\" data-gr-id=\"20\">heme</g> therapy.[1265][12347][15354]<br />\r\n<br />\r\nAttacks can also be avoided by avoiding the &lsquo;trigger&rsquo; for the attack. The trigger can be different for different people. Triggers include certain medications, alcohol, dieting, and hormonal changes in the body. Sometimes, however, the trigger is unknown. If the person with HCP has skin symptoms, avoiding excess sun exposure can reduce the blisters and skin lesions.[15354][15355]<br />\r\n<br />","dateModified":"2019-04-09T14:41:00","resourceClassificationName":"Treatment","references":[{"referenceId":1265,"authors":"Tishler, Peter","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"Updated 2014","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/hereditary-coproporphyria/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12347,"authors":"Wang B, Bissell, DM","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Nov. 8, 2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK114807/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15354,"authors":"Balwani M, Wang B, Anderson KE, Bloomer JR, Bissell DM, Bonkovsky HL, Phillips JD, Desnick RJ, et al.","articleTitle":"Acute hepatic porphyrias: recommendations for evaluation and long-term management","bookWebsiteJournalTitle":"Hepatology","date":"2017","volume":"66","pages":"1314-1322","url":"https://www.ncbi.nlm.nih.gov/pubmed/28605040","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15355,"authors":"Stein PE, Badminton MN, Rees DC.","articleTitle":"Update review of the acute porphyrias","bookWebsiteJournalTitle":"Br Jl Hemot","date":"2017","volume":"176(4)","pages":"527-538","url":"https://www.ncbi.nlm.nih.gov/pubmed/27982422","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13287,"questionText":"What is the long-term outlook for people with hereditary coproporphyria?&nbsp;","answerText":"The long term outlook for people with hereditary coproporphyria (HCP) varies with the severity of the symptoms. With early diagnosis and treatment, hereditary coproporphyria&nbsp;is rarely life-threatening.&nbsp; Some people with HCP may have long-term pain and may be at increased risk for liver and kidney disease.[12347][15354]","dateModified":"2019-04-09T14:47:00","resourceClassificationName":"Prognosis","references":[{"referenceId":12347,"authors":"Wang B, Bissell, DM","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Nov. 8, 2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK114807/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15354,"authors":"Balwani M, Wang B, Anderson KE, Bloomer JR, Bissell DM, Bonkovsky HL, Phillips JD, Desnick RJ, et al.","articleTitle":"Acute hepatic porphyrias: recommendations for evaluation and long-term management","bookWebsiteJournalTitle":"Hepatology","date":"2017","volume":"66","pages":"1314-1322","url":"https://www.ncbi.nlm.nih.gov/pubmed/28605040","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13288,"questionText":"How many people have hereditary coproporphyria?&nbsp;","answerText":"Hereditary coproporphyria (HCP) is rare.&nbsp;The exact incidence is unknown.&nbsp; One study suggested that about 1/5,000,000 people have HCP in Europe.[15357] Females are more commonly affected than males. Because this condition is often misdiagnosed and many people who have <em><a href=\"https://ghr.nlm.nih.gov/gene/CPOX\" target=\"_blank\">CPOX</a></em> mutations do not have symptoms, the incidence of this condition may be higher.&nbsp;&nbsp;","dateModified":"2019-04-09T14:57:00","resourceClassificationName":"Statistics","references":[{"referenceId":15357,"authors":"Elder G1, Harper P, Badminton M, Sandberg S, Deybach JC","articleTitle":"The incidence of inherited porphyrias in Europe","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"Sep 2013","volume":"36(5)","pages":"849-57","url":"https://www.ncbi.nlm.nih.gov/pubmed/23114748","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":1265,"authors":"Tishler, Peter","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"Updated 2014","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/hereditary-coproporphyria/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12347,"authors":"Wang B, Bissell, DM","articleTitle":"Hereditary Coproporphyria","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Nov. 8, 2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK114807/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15353,"authors":"Wang B, Rudnick S, Cengia B, Bonkovsky HL","articleTitle":"Acute hepatic porphyrias: Review and recent progress","bookWebsiteJournalTitle":"Hepato Comm","date":"Dec 20, 2018","volume":"3(2)","pages":"193-206","url":"https://www.ncbi.nlm.nih.gov/pubmed/30766957","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15354,"authors":"Balwani M, Wang B, Anderson KE, Bloomer JR, Bissell DM, Bonkovsky HL, Phillips JD, Desnick RJ, et al.","articleTitle":"Acute hepatic porphyrias: recommendations for evaluation and long-term management","bookWebsiteJournalTitle":"Hepatology","date":"2017","volume":"66","pages":"1314-1322","url":"https://www.ncbi.nlm.nih.gov/pubmed/28605040","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15355,"authors":"Stein PE, Badminton MN, Rees DC.","articleTitle":"Update review of the acute porphyrias","bookWebsiteJournalTitle":"Br Jl Hemot","date":"2017","volume":"176(4)","pages":"527-538","url":"https://www.ncbi.nlm.nih.gov/pubmed/27982422","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15356,"authors":"Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN","articleTitle":"Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene","bookWebsiteJournalTitle":"Clin Chem","date":"2009","volume":"55","pages":"1406-1414","url":"https://www.ncbi.nlm.nih.gov/pubmed/19460837","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15357,"authors":"Elder G1, Harper P, Badminton M, Sandberg S, Deybach JC","articleTitle":"The incidence of inherited porphyrias in Europe","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"Sep 2013","volume":"36(5)","pages":"849-57","url":"https://www.ncbi.nlm.nih.gov/pubmed/23114748","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":10353,"relatedDiseaseName":"Porphyria","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11011,"phenoTypeName":"Abnormal circulating porphyrin concentration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14474,"phenoTypeName":"Elevated urinary delta-aminolevulinic acid","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8269,"phenoTypeName":"Atypical scarring of skin","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13957,"phenoTypeName":"Dark urine","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5216,"phenoTypeName":"Distal muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14336,"phenoTypeName":"Episodic vomiting","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6266,"phenoTypeName":"Increased urinary porphobilinogen","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":461,"phenoTypeName":"Limb pain","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13408,"phenoTypeName":"Nausea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11012,"phenoTypeName":"Porphyrinuria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3452,"phenoTypeName":"Proximal muscle weakness in lower limbs","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3453,"phenoTypeName":"Proximal muscle weakness in upper limbs","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1325,"phenoTypeName":"Abnormal blistering of the skin","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5594,"phenoTypeName":"Back pain","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8275,"phenoTypeName":"Cutaneous photosensitivity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11377,"phenoTypeName":"Extension of hair growth on temples to lateral eyebrow","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12476,"phenoTypeName":"Facial hirsutism","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8309,"phenoTypeName":"Fragile skin","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5694,"phenoTypeName":"Hepatocellular carcinoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4310,"phenoTypeName":"Hyponatremia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6153,"phenoTypeName":"Long hairs growing from helix of pinna","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8509,"phenoTypeName":"Motor polyneuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10043,"phenoTypeName":"Nephropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6006,"phenoTypeName":"Psychosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13725,"phenoTypeName":"Respiratory insufficiency","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8012,"phenoTypeName":"Small intestinal dysmotility","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8983,"phenoTypeName":"Tachycardia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13037,"phenoTypeName":"Abnormality of metabolism/homeostasis","percentRanges":"-"},{"phenoTypeId":13599,"phenoTypeName":"Acute episodes of neuropathic symptoms","percentRanges":"-"},{"phenoTypeId":14132,"phenoTypeName":"Anxiety","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":9380,"phenoTypeName":"Confusion","percentRanges":"-"},{"phenoTypeId":9969,"phenoTypeName":"Congenital hemolytic anemia","percentRanges":"-"},{"phenoTypeId":13409,"phenoTypeName":"Constipation","percentRanges":"-"},{"phenoTypeId":6011,"phenoTypeName":"Depressivity","percentRanges":"-"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","percentRanges":"-"},{"phenoTypeId":14131,"phenoTypeName":"Hallucinations","percentRanges":"-"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","percentRanges":"-"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","percentRanges":"-"},{"phenoTypeId":7386,"phenoTypeName":"Incomplete penetrance","percentRanges":"-"},{"phenoTypeId":1855,"phenoTypeName":"Insomnia","percentRanges":"-"},{"phenoTypeId":10276,"phenoTypeName":"Jaundice","percentRanges":"-"},{"phenoTypeId":13268,"phenoTypeName":"Paranoia","percentRanges":"-"},{"phenoTypeId":2230,"phenoTypeName":"Peripheral neuropathy","percentRanges":"-"},{"phenoTypeId":8073,"phenoTypeName":"Respiratory paralysis","percentRanges":"-"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","percentRanges":"-"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Hereditary_coproporphyria"}